» Articles » PMID: 34912431

Efficacy Evaluation of Lattice Carbon Dioxide Laser Therapy in the Treatment of Postmenopausal Patients with Mild to Moderate Stress Urinary Incontinence

Overview
Journal Pak J Med Sci
Specialty General Medicine
Date 2021 Dec 16
PMID 34912431
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the efficacy and postoperative complications of lattice carbon dioxide laser in the treatment of postmenopausal patients with mild to moderate stress urinary incontinence.

Methods: A total of 30 postmenopausal female patients with mild to moderate stress urinary incontinence, recruited from the Affiliated Hospital of Hebei University from September to November 2019, were selected as the study subjects and treated with lattice carbon dioxide laser therapy. Treatment was given at intervals of one month. The degree of urinary incontinence, the urinary incontinence questionnaire (ICI-Q-SF) score, and the urinary incontinence quality of life scale (I-QOL)) Score, surgical satisfaction, one hour pad test and postoperative complications before treatment and after each treatment of all patients were respectively recorded and compared.

Results: Compared with those before treatment, the grade of urinary incontinence and ICI-Q-SF scores of these 30 patients after each treatment were lower, and their I-QOL scores were higher. The difference of one hour urine pad test was statistically significant (P<0.05), but the follow-up data of three months after the third treatment was close to that of one month after the first treatment. The satisfaction rate of these 30 patients was 76.67% (23/30). After treatment, only one patient presented vaginal itching discomfort on the first day after surgery and the symptoms disappeared three days later. No obvious complications occurred in the other 29 patients.

Conclusion: The treatment of mild and moderate postmenopausal patients with stress urinary incontinence with lattice carbon dioxide laser can effectively reduce the incidence of incontinence and improve the quality of life.

Citing Articles

CO laser therapy for management of stress urinary incontinence in women: a systematic review and meta-analysis.

Hafidh B, Baradwan S, Latifah H, Gari A, Sabban H, Abduljabbar H Ther Adv Urol. 2023; 15:17562872231210216.

PMID: 37953973 PMC: 10638870. DOI: 10.1177/17562872231210216.


Development and internal and external validation of a nomogram model for frailty risk among hospitalised older people using comprehensive geriatric assessment data.

Lyu H, Jiang W BMC Geriatr. 2023; 23(1):712.

PMID: 37919663 PMC: 10623830. DOI: 10.1186/s12877-023-04426-8.


Therapeutic effect of autologous fascia urethral suspension on female stress urinary incontinence and analysis of risk factors affecting the efficacy.

Wan X, Liu J, Lu Z, Li H, Dong J, Wang Y Am J Transl Res. 2023; 15(1):435-444.

PMID: 36777872 PMC: 9908476.

References
1.
Diez-Itza I, Zubikarai M, Galan C, Ginto L, Saro J, Arrue M . Factors involved in the persistence of stress urinary incontinence from postpartum to 12 years after first delivery. Neurourol Urodyn. 2020; 39(6):1849-1855. DOI: 10.1002/nau.24442. View

2.
Mitterberger M, Marksteiner R, Margreiter E, Pinggera G, Colleselli D, Frauscher F . Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int. 2007; 100(5):1081-5. DOI: 10.1111/j.1464-410X.2007.07119.x. View

3.
Krhut J, Zachoval R, Smith P, Rosier P, Valansky L, Martan A . Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn. 2013; 33(5):507-10. DOI: 10.1002/nau.22436. View

4.
Bai S, Kang S, Kim S, Kim J, Park K . The effect of pelvic organ prolapse on lower urinary tract function. Yonsei Med J. 2003; 44(1):94-8. DOI: 10.3349/ymj.2003.44.1.94. View

5.
Goldberg R, Sand P . Extracorporeal electromagnetic stimulation for urinary incontinence and bladder disease. Adv Exp Med Biol. 2004; 539(Pt A):453-65. DOI: 10.1007/978-1-4419-8889-8_31. View